MedTrace Logo

Characterization of Serum Proteome in Subjects With Prader Willi Syndrome (PROTEOMARKER)

NCT05761184 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2024-02-12

No results posted yet for this study

Summary

The lack of serum markers that can be used to identify the levels of steatosis in obese subjects, or that can indicate a rapid progression of the metabolic disease, in which it is very often difficult to perform analyzes with imaging techniques, limits the current evolution from a generalized medicine to a personalized medicine. With the project proposal the aim is to identify serum markers for the characterization of steatosis in subjects affected by genetic obesity, which will most likely also be used in metabolic obesity.

Conditions

Interventions

DIAGNOSTIC_TEST

Serum collection for proteomic analysis

Serum collection for proteomic analysis

Sponsors & Collaborators

  • Istituto Auxologico Italiano

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-28
Primary Completion
2022-10-28
Completion
2022-10-28

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05761184 on ClinicalTrials.gov